An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).

Clinical trial NCT00192023 · COMPLETED

Trial details

NCT number: NCT00192023
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Oppositional Defiant Disorder

Start date: 2004-10-01
Primary completion: 2006-08-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.